Bio-Techne Corporation (TECH) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Minneapolis, MN, アメリカ. 現CEOは Kim Kelderman.
TECH を有する IPO日 1989-02-09, 3,100 名の正社員, に上場 NASDAQ Global Select, 時価総額 $9.18B.
Bio-Techne Corporation is a life sciences company that develops, manufactures, and sells reagents, instruments, and diagnostic services for research and clinical markets globally. Operating through two main segments—Protein Sciences and Diagnostics and Genomics—the company offers a comprehensive portfolio including biological reagents, antibodies, cytokines, proteomic analytical tools, and diagnostic assays for oncology, genetic screening, and molecular diagnostics. Its products serve cell and gene therapy, tissue analysis, and hematology applications under recognized brands including R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, and Asuragen. Founded in 1976 and headquartered in Minneapolis, Minnesota, Bio-Techne has established itself as a trusted supplier to academic institutions, pharmaceutical companies, clinical laboratories, and diagnostic centers worldwide.
